High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal

[1]  F. Quereshy,et al.  Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline. , 2016, Current oncology.

[2]  S. Freels,et al.  Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer , 2016, Cancer.

[3]  N. Kim,et al.  High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer , 2016, Journal of Cancer Research and Clinical Oncology.

[4]  J. Pruijt,et al.  Adjuvant chemotherapy is not associated with improved survival for all high‐risk factors in stage II colon cancer , 2016, International journal of cancer.

[5]  Aalok Kumar,et al.  Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer , 2015, Cancer.

[6]  C. Lohse,et al.  Predictors of recurrence free survival for patients with stage II and III colon cancer , 2014, BMC Cancer.

[7]  Maureen A. Smith,et al.  Adjuvant Chemotherapy for Stage II Right-Sided and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data , 2014, Annals of Surgical Oncology.

[8]  B. Karabulut,et al.  Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study , 2014, Tumori.

[9]  E. Guinó,et al.  Clinicopathological risk factors of Stage II colon cancer: results of a prospective study , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[10]  K. Shirouzu,et al.  High‐risk stage II colon cancer after curative resection , 2011, Journal of surgical oncology.

[11]  T. Hickish,et al.  Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Gonen,et al.  Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant Therapy , 2008, Diseases of the colon and rectum.

[13]  D. Kerr,et al.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study , 2007, The Lancet.

[14]  R. Greil,et al.  A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer , 2007, British Journal of Cancer.

[15]  V. Moyer,et al.  Lymph node evaluation and survival after curative resection of colon cancer: systematic review. , 2007, Journal of the National Cancer Institute.

[16]  M. Somerfield,et al.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  P. Catalano,et al.  Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. P. Pignon,et al.  Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators , 1995, The Lancet.

[19]  C. Compton,et al.  The Prognosis of T3N0 Colon Cancer Is Dependent on the Number of Lymph Nodes Examined , 2003, Annals of Surgical Oncology.